TIDMN4P

RNS Number : 8771I

N4 Pharma PLC

13 August 2019

13 August 2019

N4 Pharma Plc

("N4 Pharma" or the "Company")

Holdings in Company

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec(R), a novel delivery system for vaccines and cancer treatments, announces that it has been notified that, following a purchase of 112,258 ordinary shares of 0.4p each in the company ("Ordinary Shares") earlier today, Mr David Farrier is now beneficially interested in 12,175,510 Ordinary Shares, representing 12.0 per cent. of the Company's issued share capital.

Enquiries:

 
 N4 Pharma Plc               Via Scott PR 
  Nigel Theobald, CEO 
 Allenby Capital Limited    Tel: +44(0)203 328 5656 
  James Reeve/Asha Chotai 
 Scott PR                    Tel: +44(0)1477 539 539 
  Georgia Smith 
 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments using its unique silica nanoparticle delivery system called Nuvec(R).

N4 Pharma's business model is to partner with companies developing novel antigens for vaccines and cancer treatments to use Nuvec(R) as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLLLFLITSIVLIA

(END) Dow Jones Newswires

August 13, 2019 06:16 ET (10:16 GMT)

N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas N4 Pharma.
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas N4 Pharma.